SP-MHCI-0960-3

Human Putative ankyrin repeat domain-containing protein 30B-like 145-154, ALNSEALSVV

US$507.00

In stock

Description

About Human Putative ankyrin repeat domain-containing protein 30B-like 145-154, ALNSEALSVV

The Human Ankyrin repeat domain-containing protein 30B-like Peptide (IEDB: 1312162) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Ankyrin repeat domain-containing protein Peptide, H-ALNSEALSVV-OH (Uniprot: A7E2S9  aa: 145-154) from JPT is produced under strict quality control and quality management.

Human Putative ankyrin repeat domain-containing protein 30B-like 145-154, ALNSEALSVV - Specifications

  • Peptide sequence: H-ALNSEALSVV-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Immunogenic
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human Putative ankyrin repeat domain-containing protein 30B-like 145-154, ALNSEALSVV

References:
Read References with JPT’s Antigen Peptides
Human Putative ankyrin repeat domain-containing protein 30B-like 145-154, ALNSEALSVV has been described in:
Mutational Analysis of Gene Fusions Predicts Novel MHC Class I-Restricted T-Cell Epitopes and Immune Signatures in a Subset of Prostate Cancer., Clin Cancer Res, 2017 (PMID: 28954787)
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8<sup>+</sup> and CD4<sup>+</sup> T-cell responses with multiple specificities including a novel DR7-restricted epitope., Oncoimmunology, 2016 (PMID: 27853637)

Documentation

Documentation for Human Putative ankyrin repeat domain-containing protein 30B-like 145-154, ALNSEALSVV

Properties

Properties of Human Putative ankyrin repeat domain-containing protein 30B-like 145-154, ALNSEALSVV

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Immunogenic
Layout: Freeze-dried in glass vial
Organism: Human
Protein Name: Ankyrin repeat domain-containing protein
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human Putative ankyrin repeat domain-containing protein 30B-like 145-154, ALNSEALSVV

Information Values
Sequence: H-ALNSEALSVV-OH
Specifications: 10mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote